Device therapy to modulate the autonomic nervous system to treat heart failure (Q38029559)

27 August 2017

Device therapy to modulate the autonomic nervous system to treat heart failure (English)

1 reference

27 August 2017

0 references

2

Douglas P Zipes

1 reference

27 August 2017

John C Lopshire

1

1 reference

27 August 2017

1 October 2012

1 reference

Current cardiology reports

27 August 2017

1 reference

27 August 2017

14

1 reference

27 August 2017

5

1 reference

27 August 2017

593-600

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-012-0292-8

27 August 2017

0 references

cites work

IMAGE CARDIO MED: Two different mechanisms of myocardial ischemia involving 2 separate myocardial segments in a patient with normal coronary angiography.

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Sympathetic activation in heart failure and its treatment with beta-blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Myocardial catecholamine concentrations in dilated cardiomyopathy and heart failure of different origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Cellular basis of abnormal calcium transients of failing human ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Mechanisms of sympathetic activation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Resting heart rate in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Increased neuronal nitric oxide synthase-derived NO production in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Physiology and immunology of the cholinergic antiinflammatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Intrathecal clonidine reduces the incidence of ischemia-provoked ventricular arrhythmias in a canine postinfarction heart failure model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Use of thoracic epidural anesthesia for management of electrical storm: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Spinal cord stimulation effects on myocardial ischemia, infarct size, ventricular arrhythmia, and noninvasive electrophysiology in a porcine ischemia-reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Thoracic spinal cord stimulation improves cardiac contractile function and myocardial oxygen consumption in a porcine model of ischemic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Vagus nerve stimulation in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Electrical modalities beyond pacing for the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Vagal stimulation for heart failure: background and first in-man study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0292-8

Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.

21 January 2018

1 reference

12 December 2020

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

12 December 2020

Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction

1 reference

12 December 2020

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

12 December 2020

Chronic baroreflex activation by the Rheos system: an overview of results from European and North American feasibility studies

1 reference

12 December 2020

Preemptive, but not reactive, spinal cord stimulation mitigates transient ischemia-induced myocardial infarction via cardiac adrenergic neurons

1 reference

12 December 2020

Acute and short-term effects of clonidine in heart failure

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Altered vagal and sympathetic control of heart rate in left ventricular dysfunction and heart failure.

1 reference

12 December 2020

Treatment of ventricular arrhythmia by permanent atrial pacemaker and cardiac sympathectomy

1 reference

12 December 2020

Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction

1 reference

12 December 2020

Apoptosis in the failing human heart

1 reference

12 December 2020

Effects of thoracic spinal cord stimulation on cardiac autonomic regulation of the sinus and atrioventricular nodes

1 reference

12 December 2020

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

12 December 2020

Baroreflex stimulation in the treatment of hypertension

1 reference

12 December 2020

10.1007/S11886-012-0292-8

Identifiers

DOI

1 reference

PubMed ID

22833301

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

22833301